drugset / Trial / NCT00034879
Iressa Expanded Access Program (EAP)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A program for patients with non small cell lung cancer who may benefit from Iressa, but cannot enter another clinical trial due to them not being eligible, or for whom no trials are available.
Timeline
- Start
- 2000-08
- Primary completion
- 2003-10
- Completion
- 2003-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gefitinib | Small molecule | — | — |